SCHEMBL4804758

SCHEMBL4804758

COC(=O)C1(CCc2ccccc2)CCCC1OC(=O)c1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
GPR52 Q9Y2T5 1/20 0.39
MAPT P10636 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
CHRNA7 P36544 2/20 0.38
KCNH2 Q12809 1/20 0.38
SCN2A Q99250 3/20 0.38
SCN5A Q14524 2/20 0.38
MGLL Q99685 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
LMNA P02545 3/20 0.37
SCN1A P35498 1/20 0.37
SCN3A Q9NY46 1/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4810012 0.93 CHRNA7 (0.43) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL4814363 0.92 KMT2A (0.46) L3MBTL1MEN1KMT2ANPC1RAB9A
SCHEMBL4808773 0.89 ADAM17 (0.41) NPC1RAB9AALDH1A1KDM4ESCN2A
SCHEMBL4812131 0.89 MEN1 (0.38) L3MBTL1MEN1KMT2ANPC1RAB9A
SCHEMBL4809655 0.89 RAB9A (0.43) L3MBTL1MEN1KMT2ANPC1RAB9A
SCHEMBL4813039 0.86 KMT2A (0.46) L3MBTL1MEN1KMT2ANPC1RAB9A
SCHEMBL4803641 0.85 TDP1 (0.41) KMT2ANPC1RAB9AMAPTALDH1A1
SCHEMBL4810365 0.85 BCHE (0.41) L3MBTL1MEN1KMT2AGPR52MAPT
SCHEMBL4808768 0.85 ADAM17 (0.41) NPC1RAB9AALDH1A1
SCHEMBL4806319 0.84 ALDH1A1 (0.39) L3MBTL1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388103-B2 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2008-06-17 US disclosed
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 US disclosed
WO-2006045246-A1 CYCLOPENTANE CARBOXYLATE COMPOUNDS, PROCESS AND INTERMEDIATES FOR PREPARING THE SAME AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof C5, C1S, AKR1C3 L3MBTL1 3599/4885MEN1 2837/4885KMT2A 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.